EUVIMEDExplore EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY 4.0

Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial

Jessica A Fitzpatrick iD, Peter R Gibson iD, Kirstin M Taylor iD, Ellen J Anderson iD, Antony B Friedman iD, Zaid S Ardalan iD, Rebecca L Smith iD, Emma P Halmos iD

Alimentary Pharmacology & Therapeutics · 2025-04 · 61 (8) · 1276-1289

DOI: 10.1111/apt.70041 ↗

At a glance

Randomisierte kontrollierte Studie in Alimentary Pharmacology & Therapeutics, published online on 2025-02-18. Written by Jessica A Fitzpatrick and 7 co-authors. Institution: Department of Gastroenterology, School of Translational Medicine, Monash University and Alfred Health, Melbourne, Victoria, Australia. Major MEDLINE topics: Crohn Disease, Emulsifying Agents. Cited 24 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: Eva and Tom Breuer Foundation, National Health and Medical Research Council, Crohn's and Colitis Foundation.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Background

Advice to avoid dietary emulsifiers in Crohn's disease (CD) is based on preclinical data.

Aims

To examine the effect of diets high (HED) and low (LED) in emulsifiers in the food supply on disease activity in CD.

Methods

In a double‐blinded, randomised feeding study, we randomised adults with symptomatic, sonographically active CD with ileal involvement on ≥ 2 months' stable medical therapy to 4 weeks of a HED or LED modelled on Australian healthy eating guidelines. We measured the Harvey‐Bradshaw Index (HBI), sonographic indices (IBUS‐SAS, bowel wall thickness), quality of life (QOL) and fatigue at baseline and study completion.

Results

We randomised 24 patients, mean age 37 (95% CI 32, 41) years, 12 male, HBI 6 (6, 8), bowel wall thickness 6.0 (5.5–6.6) mm. Adherence was > 95%. Clinical remission (HBI < 5) occurred in 9/12 on HED and 7/12 on LED; 2 and 3, respectively, withdrew early with increasing gastrointestinal symptoms. IBUS‐SAS fell from 51 (35, 68) to 33 (15, 51) on HED ( p = 0.014) and from 57 (38, 76) to 44 (29, 59) on LED ( p = 0.01). Bowel wall thickness reduced by 34% on HED and 15% on LED in those who completed the study. QOL and fatigue improved on both diets ( p ≤ 0.05). There were no statistically significant differences in outcomes between diets.

Conclusions

In the context of a healthy diet, the emulsifier content had no influence over disease activity over 4 weeks in patients with CD. Recommendations to avoid emulsifiers in patients with active CD are not supported. Australian New Zealand Clinical Trials Registry (ACTRN12619001099112).

Subjects

MeSH terms (MEDLINE)

Crohn DiseaseEmulsifying AgentsHumansMaleFemaleAdultDouble-Blind MethodQuality of LifeTreatment OutcomeMiddle AgedUltrasonographyYoung Adult

Author keywords

food additiveinflammationinflammatory bowel disease

Substances

Emulsifying Agents

Authors and institutions

  • Department of Gastroenterology, School of Translational Medicine, Monash University and Alfred Health, Melbourne, Victoria, Australia.

ORCID profiles: Jessica A Fitzpatrick, Peter R Gibson, Kirstin M Taylor, Ellen J Anderson, Antony B Friedman, Zaid S Ardalan, Rebecca L Smith, Emma P Halmos

Funding

  • Eva and Tom Breuer Foundation
  • National Health and Medical Research Council
  • Crohn's and Colitis Foundation
  • Crohn's and Colitis Australia

Cite

APA

Fitzpatrick, J. A., Gibson, P. R., Taylor, K. M., Anderson, E. J., Friedman, A. B., Ardalan, Z. S., Smith, R. L., & Halmos, E. P. (2025). Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial. Alimentary Pharmacology & Therapeutics, 61(8), 1276-1289. https://doi.org/10.1111/apt.70041

Vancouver

Fitzpatrick JA, Gibson PR, Taylor KM, Anderson EJ, Friedman AB, Ardalan ZS, et al. Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial. Alimentary Pharmacology & Therapeutics. 2025;61(8):1276-1289. doi:10.1111/apt.70041

BibTeX
@article{Fitzpatrick2025,
  author = {Fitzpatrick, Jessica A and Gibson, Peter R and Taylor, Kirstin M and Anderson, Ellen J and Friedman, Antony B and Ardalan, Zaid S and Smith, Rebecca L and Halmos, Emma P},
  title = {Clinical Trial: The Effects of Emulsifiers in the Food Supply on Disease Activity in Crohn's Disease: An Exploratory Double‐Blinded Randomised Feeding Trial},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {61},
  number = {8},
  pages = {1276--1289},
  doi = {10.1111/apt.70041}
}
Start for free →